Clinical Trial Update: Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin [Phase 4]

View source ↗

Summary

Phase 4 study assessing genetic predictors of variability in the drug-drug interaction between the darunavir/ritonavir combination and pravastatin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection
• Hyperlipidemia

Drugs mentioned

• Darunavir (darunavir)
• Pravastatin (pravastatin)
• Ritonavir (Ritonavir)
• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: University of Colorado, Denver | Conditions: HIV Infections, Hyperlipidemia | Phase 4 | Status: COMPLETED | Results posted: 2012-11-15